Adibendan

Adibendan

SCHEMBL9832050

CC1(C)C(=O)Nc2cc3[nH]c(-c4ccncc4)nc3cc21

nearest known ligand 0.90

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE3B Q13370 2/20 0.90
PDE3A Q14432 2/20 0.90
PDE4A P27815 1/20 0.90
PDE4B Q07343 1/20 0.90
PDE4C Q08493 1/20 0.90
PDE4D Q08499 1/20 0.90
AURKA O14965 1/20 0.55
AURKB Q96GD4 1/20 0.55
ALDH1A1 P00352 4/20 0.51
KDM4E B2RXH2 3/20 0.51
HPGD P15428 3/20 0.51
HSD17B10 Q99714 2/20 0.51
CYP1A2 P05177 1/20 0.51
CYP3A4 P08684 1/20 0.51
CYP2D6 P10635 1/20 0.51
CYP2C9 P11712 1/20 0.51
CYP2C19 P33261 1/20 0.51
RHEB Q15382 1/20 0.51
NPC1 O15118 2/20 0.50
RAB9A P51151 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Adibendan SCHEMBL10470994 0.99 PDE3B (0.88) PDE3BPDE3APDE4APDE4BPDE4C
Adibendan SCHEMBL613156 0.95 PDE3B (1.00) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL10375588 0.88 PDE4A (0.71) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL10566025 0.86 PDE3B (0.69) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL10374221 0.86 PDE4A (0.68) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL10373374 0.86 PDE3B (0.68) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL10373612 0.85 PDE4A (0.67) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL9833638 0.85 PDE4A (0.66) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL10566653 0.85 PDE3B (0.66) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL9832264 0.84 PDE4A (0.66) PDE3BPDE3APDE4APDE4BPDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0161632-B1 PYRROLO-BENZIMIDAZOLES, PROCESS FOR THEIR PREPARATION, MEDICAMENTS CONTAINING THEM AND INTERMEDIATES Roche Diagnostics GmbH (DE) 1991-04-10 EP claimed
EP-0161632-B1 PYRROLO-BENZIMIDAZOLES, PROCESS FOR THEIR PREPARATION, MEDICAMENTS CONTAINING THEM AND INTERMEDIATES Roche Diagnostics GmbH (DE) 1991-04-10 EP disclosed
US-4963686-A INTERMEDIATES FOR INOTROPIC AGENTS BOEHRINGER MANNHEIM GMBH (DE) 1990-10-16 US disclosed
US-4863945-A CARDIOVASCULAR DISORDERS BOEHRINGER MANNHEIM GMBH (DE) 1989-09-05 US disclosed
EP-0161632-A2 Pyrrolo-benzimidazoles, process for their preparation, medicaments containing them and intermediates Roche Diagnostics GmbH (DE) 1985-11-21 EP disclosed